Vincasar Pfs 1mg/ml Inj, 1ml

Manufacturer TEVA Active Ingredient Vincristine(vin KRIS teen) Pronunciation vin KRIS teen
WARNING: This drug is given into a vein only. If given other ways, this drug can be deadly. If you have questions, talk with the doctor.This drug may cause tissue damage if the drug leaks from the vein. Tell your nurse if you have any redness, burning, pain, swelling, blisters, skin sores, or leaking of fluid where the drug is going into your body. @ COMMON USES: It is used to treat cancer.
🏷️
Drug Class
Antineoplastic agent
🧬
Pharmacologic Class
Vinca alkaloid; Microtubule inhibitor
🤰
Pregnancy Category
Category D
FDA Approved
Jul 1963
⚖️
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Vincristine is a chemotherapy drug used to treat various cancers. It works by stopping cancer cells from dividing and growing, which helps to shrink tumors and control the disease. It is given as an injection into a vein.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all accompanying information. Adhere to the dosage instructions provided by your healthcare team. This medication is administered intravenously over a specified period.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the appropriate storage method.

In the event that you miss a dose, contact your doctor promptly to receive guidance on the next steps to take.
💡

Lifestyle & Tips

  • Maintain good hydration to help prevent constipation and kidney issues.
  • Eat a high-fiber diet and use stool softeners/laxatives as prescribed to prevent or manage constipation.
  • Report any new or worsening numbness, tingling, pain, or weakness in hands or feet immediately.
  • Avoid activities that require fine motor skills or balance if experiencing significant neuropathy.
  • Practice good oral hygiene to prevent mouth sores.
  • Avoid contact with people who are sick, as your immune system may be weakened.
💊

Available Forms & Alternatives

Dosing & Administration

👨‍⚕️

Adult Dosing

Standard Dose: 1.4 mg/m² IV weekly
Dose Range: 0.4 - 2 mg

Condition-Specific Dosing:

lymphoma: 1.4 mg/m² IV weekly, maximum single dose 2 mg
leukemia: 1.4 mg/m² IV weekly, maximum single dose 2 mg
multiple_myeloma: Often used in combination regimens, dose varies (e.g., 0.4 mg IV weekly)
👶

Pediatric Dosing

Neonatal: Not established
Infant: 1.5-2 mg/m² IV weekly (for children >10 kg or >1 year of age), maximum single dose 2 mg
Child: 1.5-2 mg/m² IV weekly, maximum single dose 2 mg
Adolescent: 1.4-2 mg/m² IV weekly, maximum single dose 2 mg
⚕️

Dose Adjustments

Renal Impairment:

Mild: No adjustment needed
Moderate: No adjustment needed
Severe: No adjustment needed
Dialysis: Not significantly removed by dialysis; no specific adjustment needed, but monitor for toxicity.

Hepatic Impairment:

Mild: Consider 50% dose reduction if direct bilirubin >1.5-3 mg/dL or AST >3x ULN
Moderate: Consider 50-75% dose reduction if direct bilirubin >3 mg/dL or AST >5x ULN
Severe: Consider 75% or greater dose reduction, or avoid use if severe impairment

Pharmacology

🔬

Mechanism of Action

Vincristine is a vinca alkaloid that exerts its antineoplastic effect by binding to tubulin, the structural protein of microtubules. This binding inhibits the polymerization of tubulin into microtubules, leading to the disruption of the mitotic spindle apparatus. This disruption arrests cell division in metaphase, ultimately leading to cell death. It also interferes with amino acid, cyclic AMP, and glutathione metabolism, and calmodulin-dependent Ca2+-transport ATPase activity.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100%
Tmax: Not applicable (IV administration)
FoodEffect: Not applicable

Distribution:

Vd: 2.7 ± 1.8 L/kg (large volume of distribution)
ProteinBinding: Approximately 75%
CnssPenetration: Limited

Elimination:

HalfLife: Triphasic: Initial phase 5 minutes, intermediate phase 2.3 hours, terminal phase 19-155 hours (mean 85 hours)
Clearance: Not readily available, but primarily hepatic clearance
ExcretionRoute: Primarily biliary/fecal (80%), with a small amount (12%) excreted in urine
Unchanged: Less than 10% (urine)
⏱️

Pharmacodynamics

OnsetOfAction: Rapid (cellular level)
PeakEffect: Not directly applicable for clinical effect; cellular effects are immediate
DurationOfAction: Effects persist as long as drug is present and cells are in cycle; clinical response is cumulative over weeks of therapy.

Safety & Warnings

⚠️

BLACK BOX WARNING

FOR INTRAVENOUS USE ONLY. FATAL IF GIVEN INTRATHECALLY. Vincristine sulfate is for intravenous use only. Intrathecal administration of vincristine sulfate usually results in death. Syringes containing this product should be labeled 'FOR INTRAVENOUS USE ONLY - FATAL IF GIVEN INTRATHECALLY'.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Signs of high or low blood pressure, such as:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Signs of dehydration, including:
+ Dry skin, mouth, or eyes
+ Thirst
+ Fast heartbeat
+ Dizziness
+ Fast breathing
+ Confusion
Severe constipation or stomach pain, which may indicate a severe bowel problem
Urination problems, such as:
+ Trouble passing urine
+ Pain while passing urine
+ Weak or dripping urine stream
+ Frequent urination
Nervous system problems, including:
+ Abnormal burning, numbness, or tingling sensations
+ Muscle weakness
+ Difficulty walking or changes in balance
+ Paralysis or inability to move part of the body
+ Vision loss or changes in eyesight
+ Dizziness
+ Uncontrolled eye movements
+ Seizures
+ Hearing loss (which may be long-lasting)
+ Throat, neck, or jaw pain
Signs of liver problems, such as:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes

Other Possible Side Effects

Most people experience few or no side effects while taking this medication. However, some individuals may encounter the following side effects:

Hair loss
Constipation
Diarrhea
Upset stomach
Vomiting
Decreased appetite
Stomach cramps
Weight loss
Fatigue or weakness
Headache
Back, bone, joint, or muscle pain
Mouth irritation or mouth sores

If you experience any of these side effects or any other symptoms that concern you or do not go away, contact your doctor for guidance. This is not an exhaustive list of possible side effects. If you have questions or concerns, consult your doctor.

Reporting Side Effects

You can report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch. Your doctor can also provide guidance on managing side effects and reporting them to the FDA.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe constipation or inability to have a bowel movement for several days
  • Numbness, tingling, burning pain, or weakness in hands or feet
  • Difficulty walking or foot drop
  • Fever (100.4°F or 38°C or higher) or chills
  • Sore throat, cough, or other signs of infection
  • Unusual bleeding or bruising
  • Severe abdominal pain or bloating
  • Confusion, extreme tiredness, or muscle cramps (signs of low sodium)
  • Jaw pain or pain in the glands near the ears
  • Hoarseness or voice changes
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have been diagnosed with Charcot-Marie-Tooth syndrome, a genetic disorder that affects the nerves.

This list is not exhaustive, and it is crucial to discuss all your medications, health conditions, and concerns with your doctor. Please provide your doctor and pharmacist with a comprehensive list of:

All prescription and over-the-counter (OTC) medications you are taking
Any natural products or supplements you are using
Vitamins you are taking
Any health problems or medical conditions you have

Before starting, stopping, or changing the dose of any medication, including this one, consult with your doctor to ensure your safety. It is vital to verify that it is safe to take this medication with all your other medications and health conditions.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood tests and other laboratory evaluations, as directed by your doctor, are crucial to monitor your condition.

Be aware that medications like this one can cause breathing problems, particularly when used in combination with mitomycin. These respiratory issues can occur within minutes to hours after administration and up to 2 weeks after receiving mitomycin. If you experience any difficulty breathing, contact your doctor immediately.

This medication can also lead to low blood cell counts, which may increase the risk of bleeding problems, infections, or anemia. If you notice signs of infection, such as fever, chills, or sore throat, or experience unexplained bruising or bleeding, or feel extremely tired or weak, notify your doctor right away.

If you encounter gastrointestinal side effects like stomach upset, vomiting, diarrhea, or decreased appetite, consult your doctor, as they may be able to suggest ways to minimize these effects. To manage constipation, your doctor may recommend increasing fluid intake, exercising, or adding more fiber to your diet. Additionally, your doctor can discuss the use of stool softeners or laxatives with you.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects. Similarly, if the patient is a child, this medication should be used with caution, as the risk of certain side effects may be higher in children.

This medication may affect fertility, potentially leading to difficulties in becoming pregnant or fathering a child. Although fertility may return to normal, it is essential to discuss any concerns with your doctor.

Women who may become pregnant should use birth control while taking this medication, as it may harm an unborn baby. If you become pregnant, contact your doctor immediately. If you are breast-feeding, inform your doctor, as they will need to discuss the potential risks to your baby with you.
🆘

Overdose Information

Overdose Symptoms:

  • Exaggerated side effects, particularly severe peripheral neuropathy (e.g., profound motor weakness, foot drop, paresthesias)
  • Severe constipation, paralytic ileus
  • Severe bone marrow suppression (leukopenia, thrombocytopenia, anemia)
  • Hyponatremia due to SIADH
  • Seizures, coma

What to Do:

There is no specific antidote for vincristine overdose. Management is supportive and includes: close monitoring of vital signs and neurological status, aggressive management of constipation/ileus (e.g., enemas, cathartics, neostigmine), anticonvulsants for seizures, fluid restriction for SIADH, and potentially leucovorin rescue (though efficacy is debated). Call 1-800-222-1222 (Poison Control).

Drug Interactions

🔴

Major Interactions

  • Itraconazole
  • Posaconazole
  • Voriconazole
  • Clarithromycin
  • Erythromycin
  • Ritonavir
  • Nelfinavir
  • Indinavir
  • Phenytoin (decreased phenytoin levels)
  • Digoxin (decreased digoxin absorption)
🟡

Moderate Interactions

  • Other CYP3A4 inhibitors (e.g., diltiazem, verapamil, grapefruit juice)
  • Other neurotoxic agents (e.g., paclitaxel, cisplatin, thalidomide, bortezomib)
  • Myelosuppressive agents (additive myelosuppression)
  • Live vaccines (increased risk of infection)
🟢

Minor Interactions

  • Not specifically identified as minor, but general caution with drugs affecting GI motility due to constipation risk.

Monitoring

🔬

Baseline Monitoring

Complete Blood Count (CBC) with differential and platelets

Rationale: To assess baseline bone marrow function and identify pre-existing cytopenias.

Timing: Prior to first dose

Liver Function Tests (LFTs) including bilirubin (total and direct), AST, ALT, alkaline phosphatase

Rationale: Vincristine is primarily metabolized and excreted by the liver; hepatic impairment necessitates dose adjustment.

Timing: Prior to first dose

Neurological examination (deep tendon reflexes, motor strength, sensory function)

Rationale: To establish baseline for peripheral neuropathy, a common and dose-limiting toxicity.

Timing: Prior to first dose

Bowel function assessment

Rationale: To assess baseline for constipation, a common autonomic neuropathy.

Timing: Prior to first dose

📊

Routine Monitoring

Complete Blood Count (CBC) with differential and platelets

Frequency: Prior to each dose

Target: WBC >3,000/mm³, ANC >1,500/mm³, Platelets >100,000/mm³ (may vary based on protocol)

Action Threshold: Hold dose or reduce if significant myelosuppression (e.g., ANC <1,500/mm³, platelets <100,000/mm³)

Liver Function Tests (LFTs)

Frequency: Periodically, or as clinically indicated (e.g., every 2-4 weeks or with signs of dysfunction)

Target: Within acceptable limits for protocol

Action Threshold: Dose reduction or hold if bilirubin or AST/ALT significantly elevated

Neurological examination (focus on peripheral neuropathy symptoms)

Frequency: Prior to each dose and throughout therapy

Target: Maintain baseline function as much as possible

Action Threshold: Dose reduction or discontinuation if severe or progressive neuropathy (e.g., foot drop, severe paresthesias, motor weakness)

Bowel function assessment

Frequency: Prior to each dose and throughout therapy

Target: Regular bowel movements (e.g., daily or every other day)

Action Threshold: Initiate or intensify laxative regimen if constipation develops; hold dose if severe ileus

Serum electrolytes (especially sodium)

Frequency: Periodically, or if symptoms of SIADH (e.g., confusion, lethargy)

Target: Na 135-145 mEq/L

Action Threshold: Hyponatremia (Na <130 mEq/L) may indicate SIADH, requiring fluid restriction and/or other interventions.

👁️

Symptom Monitoring

  • Peripheral neuropathy (numbness, tingling, pain in hands/feet, weakness, difficulty walking, foot drop)
  • Constipation, abdominal pain, bloating, absent bowel sounds (ileus)
  • Jaw pain, parotid pain
  • Hoarseness, vocal cord paralysis
  • Muscle cramps, weakness
  • Hair loss (alopecia)
  • Fever, chills, sore throat (signs of infection/myelosuppression)
  • Unusual bleeding or bruising
  • Shortness of breath, cough
  • Confusion, lethargy, headache (signs of SIADH or CNS effects)

Special Patient Groups

🤰

Pregnancy

Vincristine can cause fetal harm when administered to a pregnant woman. It is classified as Pregnancy Category D. Advise pregnant women of the potential risk to the fetus. Women of childbearing potential should be advised to use effective contraception during treatment and for at least 6 months after the last dose. Men should use effective contraception during treatment and for at least 3 months after the last dose.

Trimester-Specific Risks:

First Trimester: Highest risk of major congenital malformations and fetal death.
Second Trimester: Risk of fetal growth restriction and other adverse effects.
Third Trimester: Risk of fetal growth restriction and other adverse effects, potential for neonatal myelosuppression if exposed near term.
🤱

Lactation

It is not known whether vincristine is excreted in human milk. Because of the potential for serious adverse reactions in breastfed infants, breastfeeding is contraindicated during treatment with vincristine.

Infant Risk: High risk of serious adverse effects including myelosuppression, neurotoxicity, and other toxicities.
👶

Pediatric Use

Vincristine is commonly used in pediatric oncology (e.g., acute lymphoblastic leukemia, lymphomas, Wilms' tumor). Dosing is typically weight or body surface area-based. Children may be more susceptible to neurotoxicity, particularly peripheral neuropathy. Close monitoring of neurological function is essential. Constipation is also a common concern.

👴

Geriatric Use

No specific dose adjustments are generally recommended based solely on age. However, elderly patients may have reduced hepatic function, increased susceptibility to neurotoxicity, and pre-existing comorbidities that may increase the risk of adverse effects. Close monitoring of liver function, neurological status, and bowel function is crucial. Start with lower doses and titrate carefully based on tolerance and toxicity.

Clinical Information

💎

Clinical Pearls

  • **NEVER ADMINISTER INTRATHECALLY:** This is the most critical warning. Intrathecal administration is almost always fatal. Ensure all syringes are clearly labeled 'FOR INTRAVENOUS USE ONLY'.
  • **Peripheral Neuropathy:** This is the dose-limiting toxicity. Monitor for symptoms (numbness, tingling, pain, weakness, foot drop). Dose reduction or discontinuation may be necessary.
  • **Constipation:** A very common and potentially severe side effect due to autonomic neuropathy. Prophylactic bowel regimen (stool softeners, laxatives) should be initiated with the first dose and continued throughout therapy.
  • **Jaw Pain:** A common early sign of neuropathy, often transient.
  • **Hepatic Impairment:** Dose adjustments are essential in patients with liver dysfunction, as vincristine is primarily eliminated via the liver.
  • **Extravasation:** Vincristine is a vesicant. Administer through a free-flowing IV line. If extravasation occurs, stop infusion immediately, aspirate any residual drug, and manage according to institutional guidelines (e.g., hyaluronidase, warm compress).
  • **Maximum Single Dose:** The maximum single dose is typically 2 mg, regardless of BSA, to limit neurotoxicity.
🔄

Alternative Therapies

  • Other vinca alkaloids (e.g., Vinblastine, Vinorelbine - though with different toxicity profiles and indications)
  • Other antineoplastic agents depending on the specific cancer type and stage (e.g., alkylating agents, antimetabolites, topoisomerase inhibitors, targeted therapies, immunotherapies).
💰

Cost & Coverage

Average Cost: $50 - $200 per 1mg/1ml vial
Generic Available: Yes
Insurance Coverage: Specialty Tier / Tier 4 (often covered under medical benefit for oncology treatment)
📚

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure safe and effective use of your medication, never share your prescription with others, and do not take medication prescribed to someone else.

Store all medications in a secure location, out of the reach of children and pets, to prevent accidental ingestion. Properly dispose of unused or expired medications by checking with your pharmacist for guidance on the best disposal method. Unless instructed to do so, avoid flushing medications down the toilet or pouring them down the drain, as this can contaminate waterways. Many communities offer drug take-back programs, which can be an environmentally friendly way to dispose of unwanted medications.

Some medications may come with an additional patient information leaflet, so it is a good idea to check with your pharmacist for more information. If you have any questions or concerns about your medication, consult with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it was taken, as this will help healthcare professionals provide the best possible care.